Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

[1]  J. Sweatt,et al.  The Emerging Field of Neuroepigenetics , 2013, Neuron.

[2]  P. Seeman.  Are dopamine D2 receptors out of control in psychosis? , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  B. Pollock,et al.  Estimated Dopamine D2 Receptor Occupancy and Remission in Schizophrenia: Analysis of the CATIE Data , 2013, Journal of clinical psychopharmacology.

[4]  J. Haro,et al.  Analysis of Sp transcription factors in the postmortem brain of chronic schizophrenia: a pilot study of relationship to negative symptoms. , 2013, Journal of psychiatric research.

[5]  Ting Shen,et al.  Functional −141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter and schizophrenia in a Chinese Han population , 2013, The Journal of international medical research.

[6]  K. Fuxe,et al.  Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers. , 2013, Biochemical and biophysical research communications.

[7]  M. Klugmann,et al.  Imbalances in Prefrontal Cortex CC-Homer1 versus CC-Homer2 Expression Promote Cocaine Preference , 2013, The Journal of Neuroscience.

[8]  B. O'dowd,et al.  Striatal development involves a switch in gene expression networks, followed by a myelination event: Implications for neuropsychiatric disease , 2013, Synapse.

[9]  V. Pickel,et al.  Deletion of the NMDA‐NR1 receptor subunit gene in the mouse nucleus accumbens attenuates apomorphine‐induced dopamine D1 receptor trafficking and acoustic startle behavior , 2013, Synapse.

[10]  D. Rujescu,et al.  Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol , 2013, European Archives of Psychiatry and Clinical Neuroscience.

[11]  A. Samochowiec,et al.  [Associations between candidate genes with schizophrenia susceptibility and the treatment efficiency]. , 2011, Psychiatria polska.

[12]  L. Mewton,et al.  The epidemiology of DSM-IV alcohol use disorders amongst young adults in the Australian population. , 2011, Alcohol and alcoholism.

[13]  L. Fañanás,et al.  Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  Margaret A. Madigan,et al.  Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART) , 2009, Postgraduate medicine.

[15]  Rafael Franco,et al.  Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment , 2009, Psychopharmacology.

[16]  J. Hoenicka,et al.  The ANKK1 Kinase Gene and Psychiatric Disorders , 2009, Neurotoxicity Research.

[17]  G. Mengod,et al.  Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. , 2009, Cerebral cortex.

[18]  R. Catalán,et al.  Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders , 2008, Psychiatry Research.

[19]  M. Gili,et al.  Diagnostic Interview for Genetic Studies (DIGS): Inter-rater and test-retest reliability and validity in a Spanish population , 2007, European Psychiatry.

[20]  J. Hoenicka,et al.  C957T DRD2 polymorphism is associated with schizophrenia in Spanish patients , 2006, Acta psychiatrica Scandinavica.

[21]  Peter R. Martin.  Substance Abuse: A Comprehensive Textbook, 4th ed , 2006 .

[22]  Frank Telang,et al.  High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. , 2006, Archives of general psychiatry.

[23]  J. Gläscher,et al.  Pathological gambling is linked to reduced activation of the mesolimbic reward system , 2005, Nature Neuroscience.

[24]  M. Oscar-Berman,et al.  Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[25]  D. Rujescu,et al.  Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene , 2004 .

[26]  W. Maier,et al.  Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. , 2004, Archives of general psychiatry.

[27]  M. Neville,et al.  Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1 , 2004, Human mutation.

[28]  H. Ko,et al.  Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. , 2004, Alcoholism, clinical and experimental research.

[29]  J. Hoenicka,et al.  The A1 allele of the DRD2 gene (TaqI A polymorphisms) is associated with antisocial personality in a sample of alcohol-dependent patients , 2003, European Psychiatry.

[30]  Y. Lecrubier.  S.27.02 A partial D3 receptor agonist in schizophrenia , 2003, European Neuropsychopharmacology.

[31]  J. Tiihonen,et al.  Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography , 2003 .

[32]  N. Volkow,et al.  The addicted human brain: insights from imaging studies. , 2003, The Journal of clinical investigation.

[33]  C. Yiannoutsos,et al.  Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: Genetic analysis of the Milwaukee longitudinal study , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[34]  P. Guldberg,et al.  Dopa-responsive dystonia and Tourette syndrome in a large Danish family. , 2003, Archives of neurology.

[35]  S. Cichon,et al.  Association between a promoter dopamine D2 receptor gene variant and the personality trait detachment , 2003, Biological Psychiatry.

[36]  S. Purcell,et al.  The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample , 2003, Molecular Psychiatry.

[37]  V. Kaleda,et al.  Analysis of the Linkage of the Taq1A and Taq1B Loci of the Dopamine D2 Receptor Gene with Schizophrenia in Patients and Their Siblings , 2003, Neuroscience and Behavioral Physiology.

[38]  G. Koob,et al.  Alcoholism: allostasis and beyond. , 2003, Alcoholism, clinical and experimental research.

[39]  S. Schick,et al.  Severity of alcohol withdrawal symptoms and the T1128c polymorphism of the neuropeptide Y gene , 2002, Journal of Neural Transmission.

[40]  J S Fowler,et al.  Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. , 2002, Behavioural pharmacology.

[41]  R. Wightman,et al.  Transient changes in mesolimbic dopamine and their association with ‘reward’ , 2002, Journal of neurochemistry.

[42]  Yun Zhou,et al.  Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. , 2002, The American journal of psychiatry.

[43]  K. Berridge,et al.  The Neuroscience of Natural Rewards: Relevance to Addictive Drugs , 2002, The Journal of Neuroscience.

[44]  J. McGeary,et al.  The DRD4 VNTR polymorphism moderates craving after alcohol consumption. , 2002, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[45]  R. Young,et al.  D2 dopamine receptor (DRD2) polymorphism is associated with severity of alcohol dependence , 2002, European Psychiatry.

[46]  J S Fowler,et al.  Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. , 2001, The American journal of psychiatry.

[47]  S. Higuchi,et al.  Alcoholism, ALDH2*2 allele and the A1 allele of the dopamine D2 receptor gene: an association study , 2001, Psychiatry Research.

[48]  D. Comings,et al.  The additive effect of neurotransmitter genes in pathological gambling , 2001, Clinical genetics.

[49]  J. Tiihonen,et al.  Measurement of the Striatal Dopamine Transporter Density and Heterogeneity in Type 1 Alcoholics Using Human Whole Hemisphere Autoradiography , 2001, NeuroImage.

[50]  Odin van der Stelt,et al.  P3 event-related potential, dopamine D2 receptor A1 allele, and sensation-seeking in adult children of alcoholics. , 2001, Alcoholism, clinical and experimental research.

[51]  J. Tiihonen,et al.  Dopamine D2/D3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics , 2001, Molecular Psychiatry.

[52]  Yoshiro Okubo,et al.  Dopamine D2 Receptors in the Insular Cortex and the Personality Trait of Novelty Seeking , 2001, NeuroImage.

[53]  D. Rujescu,et al.  Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene. , 2001, The American journal of psychiatry.

[54]  J. Joven,et al.  Association study of schizophrenia with polymorphisms at six candidate genes , 2001, Schizophrenia Research.

[55]  J S Fowler,et al.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. , 2001, The American journal of psychiatry.

[56]  S. Kapur,et al.  Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. , 2001, The American journal of psychiatry.

[57]  G. Koob,et al.  Drug Addiction, Dysregulation of Reward, and Allostasis , 2001, Neuropsychopharmacology.

[58]  M. Grunstein,et al.  Are We Hardwired?: The Role of Genes in Human Behavior , 2000 .

[59]  Thomas J. H. Chen,et al.  The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors , 2000, Journal of psychoactive drugs.

[60]  G. Di Chiara,et al.  Stimulation of In Vivo Dopamine Transmission in the Bed Nucleus of Stria Terminalis by Reinforcing Drugs , 2000, The Journal of Neuroscience.

[61]  Jari Tiihonen,et al.  Specific binding and laterality of human extrastriatal dopamine D2/D3 receptors in late onset type 1 alcoholic patients , 2000, Neuroscience Letters.

[62]  K. Hornik,et al.  Non‐association of dopamine D4 and D2 receptor genes with personality in healthy individuals , 2000, Psychiatric genetics.

[63]  E P Noble,et al.  The DRD2 gene in psychiatric and neurological disorders and its phenotypes. , 2000, Pharmacogenomics.

[64]  G Saucier,et al.  Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder , 2000, Clinical genetics.

[65]  Graeme Eisenhofer,et al.  3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells , 2000, Brain Research.

[66]  M. Hutz,et al.  The TaqI A1 allele of the dopamine D2 receptor gene and alcoholism in Brazil: association and interaction with stress and harm avoidance on severity prediction. , 2000, American journal of medical genetics.

[67]  C. Robert Cloninger,et al.  Functional variant in the DRD2 receptor promoter region and subtypes of alcoholism. , 2000, American journal of medical genetics.

[68]  L. Mannucci,et al.  Chemical Stimulation of Synaptosomes Modulates α-Ca2+/Calmodulin-Dependent Protein Kinase II mRNA Association to Polysomes , 2000, The Journal of Neuroscience.

[69]  D. Comings,et al.  Association of the N‐acetyltransferase 1 gene (NAT1) with mild and severe substance abuse , 2000, Neuroreport.

[70]  J S Fowler,et al.  Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. , 2000, Cerebral cortex.

[71]  P. Sokoloff,et al.  Possible implications of the dopamine D3 receptor in schizophrenia and in antipsychotic drug actions , 2000, Brain Research Reviews.

[72]  C. Adler,et al.  Effects of Acute Metabolic Stress on Striatal Dopamine Release in Healthy Volunteers , 2000, Neuropsychopharmacology.

[73]  G. Koob.  Neurobiology of Addiction: Toward the Development of New Therapies , 2000, Annals of the New York Academy of Sciences.

[74]  K. Neiswanger,et al.  Personality traits and dopamine receptors (D2 and D4): linkage studies in families of alcoholics. , 1999, American journal of medical genetics.

[75]  K. Neiswanger,et al.  Linkage studies of D2 and D4 receptor genes and alcoholism. , 1999, American journal of medical genetics.

[76]  Jari Karhu,et al.  Dopamine transporter and D2-receptor density in late-onset alcoholism , 1999, Psychopharmacology.

[77]  D. Comings,et al.  Association of the enkephalinase gene with low amplitude P300 waves. , 1999, Neuroreport.

[78]  B. Everitt,et al.  Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist , 1999, Nature.

[79]  Jari Tiihonen,et al.  Dopamine transporter availability and depressive symptoms during alcohol withdrawal , 1999, Psychiatry Research: Neuroimaging.

[80]  G. Savage.  Book Review: Blackwell Dictionary of Neuropsychology , 1999 .

[81]  G. Chiara,et al.  Drug Addiction as a Disorder of Associative Learning: Role of Nucleus Accumbens Shell/Extended Amygdala Dopamine , 1999, Annals of the New York Academy of Sciences.

[82]  G. Saucier,et al.  The proenkephalin gene (PENK) and opioid dependence. , 1999, Neuroreport.

[83]  J. Heikkilä,et al.  Dopamine transporters increase in human brain after alcohol withdrawal , 1999, Molecular Psychiatry.

[84]  K A Frey,et al.  Striatal dopaminergic abnormalities in human cocaine users. , 1999, The American journal of psychiatry.

[85]  R. Young,et al.  D2 dopamine receptor and GABAA receptor β3 subunit genes and alcoholism , 1998, Psychiatry Research.

[86]  R. Todd,et al.  Association analysis in an evolutionary context: cladistic analysis of the DRD2 locus to test for association with alcoholism. , 1998, American journal of medical genetics.

[87]  C. Hodge,et al.  The discriminative stimulus effects of ethanol are mediated by NMDA and GABAA receptors in specific limbic brain regions , 1998, Psychopharmacology.

[88]  E H Cook,et al.  Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem study. , 1998, Archives of general psychiatry.

[89]  E. P. Noble.  DRD2 Gene and Alcoholism , 1998, Science.

[90]  S. Hill.  Alternative strategies for uncovering genes contributing to alcoholism risk: unpredictable findings in a genetic wonderland. , 1998, Alcohol.

[91]  E. Noble,et al.  The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes. , 1998, Alcohol.

[92]  G F Koob,et al.  Drug dependence: stress and dysregulation of brain reward pathways. , 1998, Drug and alcohol dependence.

[93]  D. Brooks,et al.  Evidence for striatal dopamine release during a video game , 1998, Nature.

[94]  T. Belin,et al.  D2 and D4 dopamine receptor polymorphisms and personality. , 1998, American journal of medical genetics.

[95]  A. Cools,et al.  Nijmegen High and Low Responders to Novelty: A New Tool in the Search After the Neurobiology of Drug Abuse Liability , 1998, Pharmacology Biochemistry and Behavior.

[96]  Daniel L. Koller,et al.  A family-based analysis of the association of the dopamine D2 receptor (DRD2) with alcoholism. , 1998, Alcoholism, clinical and experimental research.

[97]  G. Koob,et al.  The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat , 1998, Brain Research.

[98]  Stewart Tepper.  Office Practice of Neurology , 1997, Neurology.

[99]  J. Long,et al.  Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians. , 1997, American journal of medical genetics.

[100]  H. Yoneda,et al.  Association between early-onset alcoholism and the dopamine D2 receptor gene. , 1997, American journal of medical genetics.

[101]  C. C. Chen,et al.  Dopamine D2 receptor gene and alcoholism among four aboriginal groups and Han in Taiwan. , 1997, American journal of medical genetics.

[102]  O. Magnusson,et al.  Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: a microdialysis study , 1997, Neuroscience Letters.

[103]  Gregor Thut,et al.  Activation of the human brain by monetary reward , 1997, Neuroreport.

[104]  S. Walsh,et al.  Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine , 1997, Psychopharmacology.

[105]  R. Young,et al.  Association of the D2 dopamine receptor A1 allele with alcoholism: Medical severity of alcoholism and type of controls , 1997, Biological Psychiatry.

[106]  K. Chergui,et al.  Ventral pallidum self-stimulation induces stimulus dependent increase in c-fos expression in reward-related brain regions , 1997, Neuroscience.

[107]  C. Hodge,et al.  Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding. , 1996, Alcoholism, clinical and experimental research.

[108]  J S Fowler,et al.  Decreases in dopamine receptors but not in dopamine transporters in alcoholics. , 1996, Alcoholism, clinical and experimental research.

[109]  L. Parsons,et al.  Serotonin1B receptor stimulation enhances dopamine-mediated reinforcement , 1996, Psychopharmacology.

[110]  H. Hwu,et al.  Lack of association between TaqI A1 allele of dopamine D2 receptor gene and alcohol-use disorders in atayal natives of Taiwan. , 1996, American journal of medical genetics.

[111]  D. Comings,et al.  Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: A study and replication , 1996, Biological Psychiatry.

[112]  D. Comings,et al.  Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. , 1996, Molecular psychiatry.

[113]  J. Krystal,et al.  Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[114]  D. Comings,et al.  Exon and intron variants in the human tryptophan 2,3-dioxygenase gene: potential association with Tourette syndrome, substance abuse and other disorders. , 1996, Pharmacogenetics.

[115]  Thomas J. H. Chen,et al.  Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. , 1996, Pharmacogenetics.

[116]  D. Comings,et al.  The D2 Dopamine Receptor Gene as a Determinant of Reward Deficiency Syndrome , 1996, Journal of the Royal Society of Medicine.

[117]  D. Comings,et al.  A study of the dopamine D2 receptor gene in pathological gambling. , 1996, Pharmacogenetics.

[118]  D. Comings,et al.  Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes--DRD2, D beta H, and DAT1. , 1996, American journal of medical genetics.

[119]  M. Itokawa,et al.  Further association study on dopamine D2 receptor variant S311C in schizophrenia and affective disorders. , 1996, American journal of medical genetics.

[120]  T. Robbins,et al.  Neurobehavioural mechanisms of reward and motivation , 1996, Current Opinion in Neurobiology.

[121]  K. Kidd,et al.  No association between alcoholism and multiple polymorphisms at the dopamine D2 receptor gene (DRD2) in three distinct taiwanese populations , 1996, Biological Psychiatry.

[122]  John G. Cull,et al.  REWARD DEFICIENCY SYNDROME , 1996 .

[123]  F R Ervin,et al.  Altered dopamine transporter densities in alcohol‐preferring vervet monkeys , 1996, Neuroreport.

[124]  M. L. Cooper,et al.  Drinking to regulate positive and negative emotions: a motivational model of alcohol use. , 1995, Journal of personality and social psychology.

[125]  K. Neiswanger,et al.  What can the DRD2/alcoholism story teach us about association studies in psychiatric genetics? , 1995, American journal of medical genetics.

[126]  Jari Karhu,et al.  Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics , 1995, Nature Medicine.

[127]  D. Comings,et al.  Dopamine D2 receptor gene (DRD2) haplotypes and the defense style questionnaire in substance abuse, Tourette syndrome, and controls , 1995, Biological Psychiatry.

[128]  R. Young,et al.  Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele , 1995, Nature Medicine.

[129]  G. Carey.  Genetic association study in psychiatry: analytical evaluation and a recommendation. , 1994, American journal of medical genetics.

[130]  S. Hodge.  What association analysis can and cannot tell us about the genetics of complex disease. , 1994, American journal of medical genetics.

[131]  Ulla Ruotsalainen,et al.  Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence , 1994, Psychopharmacology.

[132]  K. Syndulko,et al.  D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients. , 1994, Alcohol and alcoholism.

[133]  K. Grant,et al.  Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. , 1994, Behavioural pharmacology.

[134]  T. Bouchard,et al.  Genes, environment, and personality. , 1994, Science.

[135]  M. Owen,et al.  The genetic basis of complex human behaviors. , 1994, Science.

[136]  D. Grandy,et al.  D2 dopamine receptor gene and obesity. , 1994, The International journal of eating disorders.

[137]  S. Higuchi,et al.  Aldehyde dehydrogenase genotypes In Japanese alcoholics , 1994, The Lancet.

[138]  K. Neve,et al.  Release of dopamine via the human transporter. , 1994, Molecular pharmacology.

[139]  D. Comings,et al.  The dopamine D2 receptor gene: a genetic risk factor in substance abuse. , 1994, Drug and alcohol dependence.

[140]  K. Blum,et al.  No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis. , 1994, JAMA.

[141]  J. Cano,et al.  Regulation of the prefrontal cortical dopamine release by GABAA and GABAB receptor agonists and antagonists , 1993, Brain Research.

[142]  G. Tredici,et al.  Real Complete Three-Dimensional Reconstruction of Golgi-Impregnated Neurons by Means of a Confocal Laser Scanning Microscope , 1993, NeuroImage.

[143]  K. Kidd,et al.  Population frequencies of the A1 allele at the dopamine D2 receptor locus , 1993, Biological Psychiatry.

[144]  C. Pato,et al.  Review of the putative association of dopamine D2 receptor and alcoholism: a meta-analysis. , 1993, American journal of medical genetics.

[145]  R. Crowe.  Candidate genes in psychiatry: an epidemiological perspective. , 1993, American journal of medical genetics.

[146]  G. Uhl,et al.  Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in black and Caucasian research volunteers. , 1993, Human heredity.

[147]  N Risch,et al.  The A1 allele at the D2 dopamine receptor gene and alcoholism. A reappraisal. , 1993, JAMA.

[148]  D. Goldman,et al.  DRD2 dopamine receptor genotype, linkage disequilibrium, and alcoholism in American Indians and other populations. , 1993, Alcoholism, clinical and experimental research.

[149]  K. Blum,et al.  Substance abuse vulnerability and D2 receptor genes , 1993, Trends in Neurosciences.

[150]  Y. Ueno,et al.  Genetic polymorphism of alcohol and aldehyde dehydrogenase and the effects on alcohol metabolism. , 1993, Arukoru kenkyu to yakubutsu izon = Japanese journal of alcohol studies & drug dependence.

[151]  M. Itokawa,et al.  Association between severity of alcoholism and the A1 allele of the dopamine D2 receptor gene TaqI A RFLP in Japanese , 1993, Biological Psychiatry.

[152]  D. Goldman,et al.  D2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5‐hydroxyindoleacetic acid and 3‐methoxy‐4‐hydroxyphenylglycol in alcoholics in Finland and the United States , 1992, Acta psychiatrica Scandinavica.

[153]  G. Brüning,et al.  Adaptive changes of dopamine-D2 receptors in rat brain following ethanol withdrawal: a quantitative autoradiographic investigation. , 1992, Alcohol.

[154]  R. Crowe,et al.  Alcoholism and the D2 receptor gene. , 1992, Alcoholism, clinical and experimental research.

[155]  D. Nutt,et al.  Attenuation of the behavioural effects of ethanol in mice by des-enkephalin-gamma-endorphin (ORG 5878). , 1992, Alcohol and alcoholism.

[156]  J. Lowinson.  Substance Abuse: A Comprehensive Textbook , 1992 .

[157]  J. Kelsoe,et al.  Lack of association between an RFLP near the D2 dopamine receptor gene and severe alcoholism , 1992, Biological Psychiatry.

[158]  P Kocsis,et al.  The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. , 1991, JAMA.

[159]  K. Kidd,et al.  No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. , 1991, JAMA.

[160]  K. Blum,et al.  Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. , 1991, Alcohol.

[161]  C. Robert Cloninger,et al.  Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage. , 1991, Archives of general psychiatry.

[162]  D. Grandy,et al.  Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor gene. , 1991, Genomics.

[163]  E P Noble,et al.  Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. , 1991, Archives of general psychiatry.

[164]  D. Goldman,et al.  Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. , 1990, JAMA.

[165]  K. Blum,et al.  Allelic association of human dopamine D2 receptor gene in alcoholism. , 1990, JAMA.

[166]  K. Merikangas.  The genetic epidemiology of alcoholism , 1990, Psychological Medicine.

[167]  D. Grandy,et al.  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.

[168]  G. Di Chiara,et al.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[169]  D. Rowe,et al.  GENETIC AND ENVIRONMENTAL COMPONENTS OF ANTISOCIAL BEHAVIOR: A STUDY OF 265 TWIN PAIRS* , 1986 .

[170]  F. Muntoni,et al.  Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area , 1985, Brain Research.

[171]  D. de Wied,et al.  Pre-decapitation state of arousal of rats predetermines the effect of des-Tyr1-gamma-endorphin on dopamine release from nucleus accumbens slices in vitro. , 1984, Life sciences.

[172]  W. Verhoeven,et al.  THE USE OF THE SYNTHETIC PEPTIDES γ‐TYPE ENDORPHINS IN MENTALLY ILL PATIENTS , 1982 .

[173]  J. M. Ree,et al.  Non-opiate β-endorphin fragments and dopamine—III γ-type endorphins and various neuroleptics counteract the hypoactivity elicited by injection of apomorphine into the nucleus accumbens , 1982, Neuropharmacology.

[174]  Kudrin Vs,et al.  [Des-1-tyrosine-gamma-endorphin: an assessment of its neuroleptic properties and effect on dopamine synthesis]. , 1982 .

[175]  N. Ling,et al.  Identification of β-endorphin-(6–17) as the principal metabolite of des-tyrosine-γ-endorphin (DTγE) in vitro and assessment of its activity in neurotransmitter receptor binding assays , 1982 .

[176]  W. Gispen,et al.  Modulation of ACTH-induced grooming by [DES-TYR1]-γ-endorphin and haloperidol , 1980 .

[177]  Colpaert Fc.  Neuropeptides and addiction , 1979 .

[178]  W. Verhoeven,et al.  Improvement of Schizophrenic Patients Treated With Des-Tyr1]-γ-endorphin (DTγE) , 1979 .

[179]  J. Leysen,et al.  Interaction of des-tyrosine-γ-endorphin (DTγE,β-LPH62–77) with neuroleptic binding sites in various areas of rat brain , 1978 .

[180]  J. M. Ree,et al.  Neuroleptic activity of the neuropeptide β-LPH62–77 ([Des-Tyr1]γ-endorphin; DTγE) , 1978 .

[181]  L. Stein,et al.  The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system , 1977, Neuroscience Letters.

[182]  C. Davenport.  THE IMPORTANCE OF ESTABLISHING SPECIFIC PLACE-MODES. , 1899, Science.

[183]  Yanyan Wang,et al.  A molecular genetic approach to uncovering the differential functions of dopamine D2 receptor isoforms. , 2013, Methods in molecular biology.

[184]  J. Ramos,et al.  Cannabinoids and gene expression during brain development , 2009, Neurotoxicity Research.

[185]  D. Wied,et al.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression , 2009, Neurotoxicity research.

[186]  B. Riley.  Linkage studies of schizophrenia , 2009, Neurotoxicity Research.

[187]  J. Hoenicka,et al.  Association in alcoholic patients between Psychopathic Traits and the additive effect of allelic forms of theCNR1 andFAAH endocannabinoid genes, and the 3′ Region of theDRD2 Gene , 2009, Neurotoxicity Research.

[188]  A. Malhotra.  Candidate gene studies of antipsychotic drug efficacy and drug-induced weight gain , 2009, Neurotoxicity Research.

[189]  P. Sokoloff,et al.  Dopamine and glutamate dysfunctions in schizophrenia: Role of the dopamine D3 receptor , 2009, Neurotoxicity Research.

[190]  Thomas J. H. Chen,et al.  Preliminary association of both the Dopamine D2 Receptor (DRD2) (Taq1 A1 Allele) and the Dopamine Transporter (DAT1) (480 bp Allele) genes with pathological aggressive behavior, a clinical subtype of Reward Deficiency Syndrome (RDS) in adolescents , 2007 .

[191]  Thomas J. H. Chen,et al.  Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disorders. , 2005, Medical hypotheses.

[192]  R. Cadoret,et al.  Genetic and environmental factors in adoptee antisocial personality , 2005, European archives of psychiatry and neurological sciences.

[193]  N. Oakley,et al.  Effect of typical and atypical neuroleptics on the behavioural consequences of activation by muscimol of mesolimbic and nigro-striatal dopaminergic pathways in the rat , 2005, Psychopharmacology.

[194]  M. Schuckit,et al.  Association of GABRG3 with alcohol dependence. , 2004, Alcoholism, clinical and experimental research.

[195]  E. Noble,et al.  D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes , 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[196]  C. Pato,et al.  Association and linkage disequilibrium between a functional polymorphism of the dopamine-2 receptor gene and schizophrenia in a genetically homogeneous Portuguese population , 2002, Molecular Psychiatry.

[197]  G. Di Chiara.  Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. , 2002, Behavioural brain research.

[198]  S. Fuchs,et al.  Ethanol acts synergistically with a D2 dopamine agonist to cause translocation of protein kinase C. , 2001, Molecular pharmacology.

[199]  D. Comings,et al.  Reward deficiency syndrome: genetic aspects of behavioral disorders. , 2000, Progress in brain research.

[200]  P. Gorwood.  Apport de la génétique dans le concept de terrain à risque pour l'alcoolo-dépendance , 2000 .

[201]  P. Gorwood.  [Contribution of genetics to the concept of risk status for alcohol dependence]. , 2000, Journal de la Societe de biologie.

[202]  R. Myers,et al.  Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats. , 1999, Alcohol.

[203]  G. Di Chiara.  Drug addiction as dopamine-dependent associative learning disorder. , 1999, European journal of pharmacology.

[204]  J. Karhu,et al.  Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging , 1998, European Journal of Nuclear Medicine.

[205]  R Kötter,et al.  Useless or Helpful? The "Limbic System" Concept , 1997, Reviews in the neurosciences.

[206]  D. Comings,et al.  Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors , 1997, Molecular Psychiatry.

[207]  J. Graham Beaumont,et al.  The Blackwell dictionary of neuropsychology , 1996 .

[208]  H. Nicolini,et al.  The dopamine D2 receptor gene TaqI A1 polymorphism and alcoholism in a Mexican population. , 1995, Archives of medical research.

[209]  C. Robert Cloninger,et al.  Linkage disequilibria at the D2 dopamine receptor locus (DRD2) in alcoholics and controls. , 1994, Genomics.

[210]  K. Kendler,et al.  The genetics of schizophrenia: a current, genetic-epidemiologic perspective. , 1993, Schizophrenia bulletin.

[211]  K. Blum,et al.  Genetic predisposition in alcoholism: association of the D2 dopamine receptor TaqI B1 RFLP with severe alcoholics. , 1993, Alcohol.

[212]  D. Greenberg,et al.  Linkage analysis of "necessary" disease loci versus "susceptibility" loci. , 1993, American journal of human genetics.

[213]  D. Lykken,et al.  Heterogeneity in the inheritance of alcoholism. A study of male and female twins. , 1991, Archives of general psychiatry.

[214]  A. Yoshida,et al.  Genetics of human alcohol-metabolizing enzymes. , 1991, Progress in nucleic acid research and molecular biology.

[215]  H J Edenberg,et al.  Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. , 1989, The Journal of clinical investigation.

[216]  J. M. Ree,et al.  Neuroleptic-like profile of γ-type endorphins as related to schizophrenia , 1982 .

[217]  V. Kudrin,et al.  [Des-1-tyrosine-gamma-endorphin: an assessment of its neuroleptic properties and effect on dopamine synthesis]. , 1982, Farmakologiia i toksikologiia.

[218]  N. Ling,et al.  Identification of beta-endorphin-6(16-17) as the principal metabolite of des-tyrosin-gamma-endorphin (DTgammaE) in vitro and assessment of its activity in neurotransmitter receptor binding assays. , 1982, European journal of pharmacology.

[219]  W. Verhoeven,et al.  The use of the synthetic peptides gamma-type endorphins in mentally ill patients. , 1982, Annals of the New York Academy of Sciences.

[220]  W. Gispen,et al.  Modulation of ACTH-induced grooming by [Des-Tyr1]-gamma-endorphin and haloperidol. , 1980, European journal of pharmacology.

[221]  J. van Ree.  [Neuropeptides and addiction]. , 1979, Nederlands tijdschrift voor geneeskunde.

[222]  W. Verhoeven,et al.  Improvement of schizophrenic patients treated with [des-Tyr1]-gamma-endorphin (DTgammaE). , 1979, Archives of general psychiatry.

[223]  S. Snyder,et al.  The dopamine hypothesis of schizophrenia: focus on the dopamine receptor. , 1976, The American journal of psychiatry.